tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HLS Therapeutics price target raised to C$4.75 from C$4 at Stifel
The FlyHLS Therapeutics price target raised to C$4.75 from C$4 at Stifel
3d ago
Positive Outlook for HLS Therapeutics Inc. Amid Regulatory Developments and Product Approvals
PremiumRatings
Positive Outlook for HLS Therapeutics Inc. Amid Regulatory Developments and Product Approvals
29d ago
HLS Therapeutics Gains Health Canada Approval for NILEMDO®
PremiumCompany Announcements
HLS Therapeutics Gains Health Canada Approval for NILEMDO®
1M ago
HLS Therapeutics Inc.: Strategic Resilience and Growth Potential Amidst Market Challenges
PremiumRatings
HLS Therapeutics Inc.: Strategic Resilience and Growth Potential Amidst Market Challenges
1M ago
HLS Therapeutics Reports Mixed Earnings Amid Growth Challenges
PremiumCompany Announcements
HLS Therapeutics Reports Mixed Earnings Amid Growth Challenges
1M ago
HLS Therapeutics Reports Strong Q3 2025 Results and Prepares for New Product Launch
PremiumCompany AnnouncementsHLS Therapeutics Reports Strong Q3 2025 Results and Prepares for New Product Launch
1M ago
HLS Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
HLS Upcoming Earnings Report: What to Expect?
1M ago
HLS Therapeutics to Announce Q3 2025 Financial Results
Premium
Company Announcements
HLS Therapeutics to Announce Q3 2025 Financial Results
2M ago
HLS Therapeutics and Amarin Highlight Cardiovascular Advances at Canadian Congress
PremiumCompany Announcements
HLS Therapeutics and Amarin Highlight Cardiovascular Advances at Canadian Congress
2M ago
HLS Therapeutics Secures New Credit Agreement for Financial Flexibility
PremiumCompany Announcements
HLS Therapeutics Secures New Credit Agreement for Financial Flexibility
4M ago
HLS Therapeutics Inc: Strong Q2 Performance and Optimistic Outlook Justify Buy Rating
PremiumRatings
HLS Therapeutics Inc: Strong Q2 Performance and Optimistic Outlook Justify Buy Rating
4M ago
HLS Therapeutics Reports Strong Q2 2025 Financials and Strategic Expansion
PremiumCompany Announcements
HLS Therapeutics Reports Strong Q2 2025 Financials and Strategic Expansion
4M ago
HLS Earnings this Week: How Will it Perform?
PremiumPre-EarningsHLS Earnings this Week: How Will it Perform?
4M ago
HLS Therapeutics to Announce Q2 2025 Financial Results
Premium
Company Announcements
HLS Therapeutics to Announce Q2 2025 Financial Results
5M ago
HLS Therapeutics Secures Nova Scotia Reimbursement for Vascepa
Premium
Company Announcements
HLS Therapeutics Secures Nova Scotia Reimbursement for Vascepa
6M ago
HLS Therapeutics Announces Strong Shareholder Support at Annual Meeting
PremiumCompany Announcements
HLS Therapeutics Announces Strong Shareholder Support at Annual Meeting
6M ago
HLS Therapeutics Inc.: Strategic Positioning and Growth Potential Justify Buy Rating
PremiumRatings
HLS Therapeutics Inc.: Strategic Positioning and Growth Potential Justify Buy Rating
7M ago
HLS Therapeutics Partners with Esperion to Bring Cardiovascular Treatments to Canada
PremiumCompany Announcements
HLS Therapeutics Partners with Esperion to Bring Cardiovascular Treatments to Canada
8M ago
HLS Therapeutics Reports Q1 2025 Growth and Strategic Expansion
PremiumCompany Announcements
HLS Therapeutics Reports Q1 2025 Growth and Strategic Expansion
8M ago
HLS Therapeutics to Present at 2025 Healthcare Investor Conference
PremiumCompany AnnouncementsHLS Therapeutics to Present at 2025 Healthcare Investor Conference
8M ago
HLS Therapeutics to Announce Q1 2025 Financial Results
Premium
Company Announcements
HLS Therapeutics to Announce Q1 2025 Financial Results
8M ago
HLS Therapeutics Inc. Receives Buy Rating Amid Strong Financial Performance and Positive 2025 Guidance
Premium
Ratings
HLS Therapeutics Inc. Receives Buy Rating Amid Strong Financial Performance and Positive 2025 Guidance
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >